ENTR-601-44, SODIUM CHLORIDE
ENTR-601-44-201
Phase 2 small_molecule active
Quick answer
ENTR-601-44, SODIUM CHLORIDE for Duchenne Muscular Dystrophy is a Phase 2 program (small_molecule) at Entrada Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Entrada Therapeutics
- Indication
- Duchenne Muscular Dystrophy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active